Melanie Gloria is the Chief Operating Officer at Immunovant Inc., a biotechnology company dedicated to developing innovative therapies for autoimmune diseases. With over 15 years of experience in the biopharmaceutical industry, Gloria began her career after earning a Bachelor’s degree in Biology from the University of California, Berkeley, and an MBA from Harvard Business School. She started in operational roles at smaller biotech firms, where she honed her skills in clinical trial management and strategic planning. Prior to joining Immunovant, Gloria served as Vice President of Operations at a leading pharmaceutical company, where she led cross-functional teams to streamline processes and accelerate drug development pipelines, demonstrating her expertise in navigating complex regulatory environments and fostering collaborative partnerships. Throughout her career, Gloria has achieved significant milestones, including overseeing